Bacteriophage Therapy of Bacterial Infections: an Update of Our Institute's Experience

Overview

Journal Arch Immunol Ther Exp (Warsz)

Publisher Sciendo

Specialty Allergy & Immunology

Date 2001 Feb 24

PMID 11197610

Citations 68

Authors

B Weber-Dabrowska

M MULCZYK

A Gorski

Affiliations

Soon will be listed here.

Abstract

1307 patients with suppurative bacterial infections caused by multidrug-resistant bacteria of different species were treated with specific bacteriophages (BP). BP therapy was highly effective; full recovery was noted in 1123 cases (85.9%). In 134 cases (10.9%) transient improvement was observed and only in 50 cases (3.8%) was BP treatment found to be ineffective. The results confirm the high effectiveness of BP therapy in combating bacterial infections which do not respond to treatment with the available antibiotics.

Citing Articles

Selected Mechanisms of Action of Bacteriophages in Bacterial Infections in Animals.

Urban-Chmiel R, Pyzik E Viruses. 2025; 17(1).

PMID: 39861891 PMC: 11768571. DOI: 10.3390/v17010101.

Phage therapy: A novel approach against multidrug-resistant pathogens.

Kapoor A, Mudaliar S, Bhat V, Chakraborty I, Prasad A, Mazumder N 3 Biotech. 2024; 14(10):256.

PMID: 39355200 PMC: 11442959. DOI: 10.1007/s13205-024-04101-8.

Emerging Microorganisms and Infectious Diseases: One Health Approach for Health Shared Vision.

Ristori M, Guarrasi V, Soda P, Petrosillo N, Gurrieri F, Longo U Genes (Basel). 2024; 15(7).

PMID: 39062687 PMC: 11275270. DOI: 10.3390/genes15070908.

Bacteriophage therapy in musculoskeletal infections: from basic science to clinical application.

Ferry T, Onsea J, Roussel-Gaillard T, Batailler C, Moriarty T, Metsemakers W EFORT Open Rev. 2024; 9(5):339-348.

PMID: 38726986 PMC: 11099583. DOI: 10.1530/EOR-24-0042.

The Medicinal Phage-Regulatory Roadmap for Phage Therapy under EU Pharmaceutical Legislation.

Faltus T Viruses. 2024; 16(3).

PMID: 38543808 PMC: 10974108. DOI: 10.3390/v16030443.